<DOC>
	<DOCNO>NCT00271791</DOCNO>
	<brief_summary>The purpose study investigate value steroid treatment vestibular neuronitis . The potential benefit steroid therapy would analyze clinical response , self-perceived handicap laboratory parameter .</brief_summary>
	<brief_title>Prednisone Treatment Vestibular Neuronitis</brief_title>
	<detailed_description>Vestibular neuronitis second common cause peripheral vestibulopathy ( first benign paroxysmal positional vertigo ) incidence 3.5/100000 . Currently vestibular neuronitis explain viral pathogenesis . Vestibular neuronitis consider benign course . The static rotatory vertigo disequilibrium , present even patient completely rest , subside case within day , gradual return daily activity rule . However , show generally incomplete restoration peripheral function , clinical recovery achieve proprioceptive visual substitution unilateral vestibular deficit , combine central vestibular compensation imbalance vestibular tone . Although vestibular neuronitis usually restrict one attack , several study report continuous episodic vertigo unsteadiness 43 % -53 % patient . The main residuum include impaired vision disequilibrium walk especially head movement toward affected ear . The rate positive finding vestibular evaluation may reach 60 % . However , vestibular impairment reflect positive bedside test vestibular laboratory evaluation necessarily accompany subjective complaint always reflect level incapacity . The assumed HSV-1 etiology vestibular neuronitis report benefit combination steroid acyclovir Bell 's palsy suggest similar advantage treatment vestibular neuronitis . Also , glucocorticoid receptor activation report enhance vestibular compensation acute peripheral vestibular insult various animal model . A recent study investigate effect prednisolone versus valacyclovir placebo canal paresis vestibular neuronitis patient . It find steroid treatment significantly improve peripheral vestibular function extent reflect caloric testing . However , bedside finding , patient ' complaint daily handicap evaluate . The relevance EOG caloric test result clinical improvement could argue light previous report show correlation EOG finding residual symptom long-term follow-up vestibular neuronitis patient , find corticosteroid therapy effect symptom despite significant recovery caloric-test result . The purpose study : Prospective control longitudinal 12-month evaluation value steroid treatment vestibular neuronitis . The potential benefit steroid therapy would analyze clinical response , self-perceived handicap EOG laboratory parameter .</detailed_description>
	<mesh_term>Vestibular Diseases</mesh_term>
	<mesh_term>Neuritis</mesh_term>
	<mesh_term>Vestibular Neuronitis</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Clinical diagnosis vestibular neuronitis . Documentation unilateral reduce caloric response ( caloric asymmetry &gt; 25 % ) EOG caloric study . Complaints new hearing loss , tinnitus , neurological deficit . The presence previously nondiagnosed sensorineural hearing loss ( SNHL ) History vestibular dysfunction . Patient young 18 year age . Known contraindication systemic steroid : Unbalanced hypertension , uncontrolled diabetes mellitus , immunodeficiency , active peptic disease , avascular necrosis femoral head .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Vestibular Neuronitis</keyword>
	<keyword>Vestibular Function Tests</keyword>
	<keyword>Vestibular Adaptation</keyword>
	<keyword>Steroids</keyword>
</DOC>